Novo Holdings to Acquire Benchmark Genetics
Novo Holdings, the Denmark-based holding and investment company responsible for managing the assets and the wealth of the Novo Nordisk Foundation, just announced that it will acquire the Norwegian fish genetics company Benchmark Genetics from Benchmark Holdings plc for an enterprise value of up to £260 million.
Benchmark Genetics is an aquaculture biotechnology company headquartered in Bergen, Norway, with customers in more than 50 countries and breeding centers located in Norway, Iceland, Chile, the U.S., and Colombia. A leader in aquaculture genetics, Benchmark Genetics employs more than...
To Read Full Story Login Below.